Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

50.76
Delayed Data
As of Aug 29
 0.00 / 0.00%
Today’s Change
38.26
Today|||52-Week Range
52.64
+5.93%
Year-to-Date
Bill Ackman Comments on Zoetis Inc.
Aug 29 / GuruFocus News - Paid Partner Content
Top Research Reports for August 19, 2016
Aug 19 / Zacks.com - Paid Partner Content
Activist funds set their sights on microcaps
Aug 28 / FT.com - Paid Partner Content
5 Top ROE Stocks to Play in an Aging Bull Market
Aug 19 / Zacks.com - Paid Partner Content
Eli Lilly, AstraZeneca Alzheimer's Drug Gets FDA Fast Track
Aug 23 / Zacks.com - Paid Partner Content
2 Stocks Bill Ackman Is Dumping
Aug 17 / MotleyFool.com - Paid Partner Content
Zacks.com featured highlights: Macy's, Discovery Communications, Zoetis, Boston Scien...
Aug 22 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close50.76
Today’s open50.76
Day’s range50.42 - 50.96
Volume2,370,656
Average volume (3 months)3,344,209
Market cap$25.1B
Dividend yield0.75%
Data as of 08/29/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+7.20%
Earnings growth (next 5 years)+13.20%
Revenue growth (last year)-0.42%
P/E ratio39.7
Price/Sales5.05
Price/Book23.64

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...+0.23+0.49%
VRTXVertex Pharmaceutica...-0.15-0.15%
MYLMylan NV+0.19+0.44%
ALXNAlexion Pharmaceutic...-1.64-1.27%
Data as of 08/29/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.46
Annual revenue (last year)$4.8B
Annual profit (last year)$339.0M
Net profit margin7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts

Partner Offers

Search for Jobs